{"filings":[{"id":787007,"accession_number":"0001104659-26-069119","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K/A","filed_at":"2026-06-02T01:02:57+00:00","items":["5.02","9.01"],"status":"ready","headline":"AdaptHealth amends 8-K to disclose COO Daniel McFadden's compensation: base salary raised to $550K, plus RSU grant","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary increased from $410K to $550K retroactive to May 4, 2026.","Annual target bonus set at 100% of base salary, pro-rated for FY2026.","One-time RSU grant valued at $464,110 with time-based (50%, 3-yr) and TSR-based (50%, 0-200%) vesting.","Grant is under the Second Amended and Restated 2019 Stock Incentive Plan.","This amends prior filing to correct date and add compensation details not previously determined."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95018,"accession_number":"0001628280-26-030120","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"AdaptHealth Q1 net loss widens to $16M, COO replaced; raises revenue guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $819.8M (+5.4% YoY); net loss $16.0M vs $7.2M loss in Q1 2025.","Adjusted EBITDA $121.2M, down 5.3% YoY; free cash flow negative $27.5M.","FY 2026 net revenue guidance raised $10M to $3.45-3.52B; EBITDA and FCF guidance maintained.","COO Toby Scott Barnhart terminated May 4; replaced by Daniel McFadden (Chief Business Systems Officer).","Completed $1.1B refinancing in April, reducing near-term amortization and lowering average debt cost."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":819799000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95017,"accession_number":"0001628280-26-024835","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2026-04-13T23:59:59+00:00","items":["1.01","1.02","2.03","7.01","9.01"],"status":"ready","headline":"AdaptHealth closes $1.1B credit facility with reduced pricing and extended maturity to 2031","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New facility: $325M term loan, $325M delayed draw term loan, $450M revolver (previously $300M).","Proceeds repaid existing term loan and $100M drawn revolver; no penalty.","Delayed draw facility to redeem $325M 6.125% Senior Notes due 2028 when callable at par in Aug 2026.","Pricing grid reduced to 1.125%–2.000% over SOFR; weighted avg cost of debt to decrease by at least 25 bps after note redemption.","Maturity extended ~2 years to April 2031; no impact on previously issued FY2026 guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107787,"accession_number":"0001628280-26-010872","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth reports Q4 net loss $102.8M, FY net loss $70.8M; guides FY2026 rev up to $3.51B, EBITDA $680-730M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2025 net loss $70.8M vs net income $90.4M in 2024; includes $128M goodwill impairment.","Q4 2025 net revenue $846.3M (-1.2% YoY); Adjusted EBITDA $163.1M (-18.7%).","FY 2025 Adjusted EBITDA $616.7M (-10.5%); free cash flow $219.4M.","2026 guidance: Net revenue $3.44B-$3.51B, Adjusted EBITDA $680M-$730M, free cash flow $175M-$225M.","Debt reduced $250M in FY 2025; credit upgrades from S&P and Moody's; patient census records set."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":3244857000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124180,"accession_number":"0001628280-25-048527","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q3 net revenue $820.3M (+1.8%), adj. EBITDA $170.1M (+3.5%) beat expectations; organic growth 5.1%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $24.5M vs $22.9M; YTD free cash flow $140.1M vs $162.7M.","Reduced debt by $225M YTD; net leverage ratio 2.68x (target 2.50x).","Signed capitated HME deal for ~170k members; myApp users up 271k from 118k.","Maintained FY2025 guidance: rev $3.18-3.26B, adj. EBITDA $642-682M, FCF $170-190M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":2398568000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140844,"accession_number":"0001628280-25-037598","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q2 2025 revenue $800.4M, net income $14.7M; lowers FY adjusted EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $800.4M, down 0.7% YoY; net income $14.7M vs $19.4M in prior year.","Adjusted EBITDA $155.5M, down 5.9% YoY; year-to-date cash flow from ops $257.5M.","FY 2025 revenue guidance narrowed to $3.18B-$3.26B; adjusted EBITDA lowered to $642M-$682M.","Closed sales of certain incontinence and infusion assets in Wellness at Home segment.","Announces new capitated partnership with a major national healthcare system (no details)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":1578254000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140843,"accession_number":"0001104659-25-073912","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"AdaptHealth signs exclusive 5-year capitated HME partnership with major national health system covering 10M+ members","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Partnership with a large California-based integrated delivery network; exclusive provider of HME for its 10M+ members.","5-year capitated agreement covering Medicare Advantage, Medicaid Managed Care, and privately insured patients.","CEO Suzanne Foster says the deal demonstrates AdaptHealth's ability to drive non-acquired growth through innovative arrangements.","Agreement shifts to capitation payment model, providing predictable revenue stream across a large patient base."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158593,"accession_number":"0001104659-25-064140","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-06-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"AdaptHealth closes infusion asset sale, reduces debt by $65M, updates FY2025 guidance","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed disposition of certain infusion assets in Wellness at Home segment; assets had ~$52M annual revenue and ~$5M annual Adjusted EBITDA.","Used proceeds for $65M term loan prepayment; cumulative $135M debt reduction (including $70M prepayment in May).","Revised FY2025 guidance: revenue $3,150M-$3,290M; Adjusted EBITDA $662M-$702M; Free Cash Flow $170M-$190M.","Company expects $30M cash taxes on gains from this disposition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158592,"accession_number":"0001104659-25-061172","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-06-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"AdaptHealth stockholders elect six directors, ratify KPMG, approve executive compensation","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected: Connors, Coppens, Lundberg, Weaver, Williams III, Wolf.","KPMG LLP ratified as independent auditor for FY2025: 124.3M for, 2.1M against, 112K abstain.","Non-binding advisory vote on executive compensation approved: 105.7M for, 6.4M against, 14.3M broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158591,"accession_number":"0001628280-25-022394","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q1 revenue down 1.8% to $778M; net loss widens; guides FY25 lower on asset sales","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $777.9M (-1.8% YoY); net loss $7.2M vs $2.1M loss prior year.","Adjusted EBITDA $127.9M (-19.3% YoY); operating cash flow improved to $95.5M.","Sold incontinence assets; signed deal to sell infusion assets (closes Q2 2025).","FY2025 guidance reduced: revenue $3.18B-$3.32B, Adj. EBITDA $665M-$705M.","Diabetes segment improved for second consecutive quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":777882000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176985,"accession_number":"0001628280-25-007553","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth reports FY2024 net income of $90.4M vs prior year loss; revenue up 1.9%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2024 net revenue $3.261B (+1.9% YoY); net income attributable $90.4M vs net loss $678.9M.","Adjusted EBITDA $688.7M (+2.7% YoY); cash flow from ops $541.8M, free cash flow $235.8M.","Q4 net revenue $856.6M (-0.2% YoY); net income $50.3M vs loss $254.5M; adjusted EBITDA $200.6M.","FY2025 guidance: net revenue $3.22B-$3.36B; adjusted EBITDA $670M-$710M; free cash flow $180M-$220M.","Reached definitive agreement to sell certain incontinence assets in Wellness at Home segment."],"consensus_eps_estimate":null,"consensus_eps_actual":0.61,"consensus_revenue_estimate":null,"consensus_revenue_actual":3260975000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193772,"accession_number":"0001104659-24-128292","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-12-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"AdaptHealth cuts CBO Rietkerk's salary to $125k amid transition; separation March 31","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Shaw Rietkerk's annual base salary reduced from $500,000 to $125,000 effective January 1, 2025.","Amendment to August 2024 transition agreement; separation date remains March 31, 2025.","All other terms of prior transition agreement unchanged.","CEO Suzanne Foster countersigned the amendment on December 9, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193771,"accession_number":"0001628280-24-045113","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q3 net income $22.9M, revenue $805.9M; raises free cash flow guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income attributable to AdaptHealth of $22.9M vs net loss of $454.1M in Q3 2023.","Revenue $805.9M, up 0.2% YoY; Adjusted EBITDA $164.3M, up 1.9%.","FY 2024 guidance updated: revenue $3.22-3.26B (down), adjusted EBITDA $655-675M (narrowed), free cash flow $175-195M (up from $160-180M).","Year-to-date free cash flow $162.7M, more than double prior year's $76.6M.","Completed sale of certain custom rehab assets during the quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":2404330000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193770,"accession_number":"0001104659-24-112672","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"AdaptHealth enters new CTO employment agreement with Albert Prast; base salary $450K","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Annual base salary of $450,000; target annual bonus of 100% of base salary.","Eligible for equity awards beginning 2025; Compensation Committee intends $1M annual grant.","Severance: 18 months base salary continuation plus COBRA on qualifying termination.","Restrictive covenants include 18-month non-compete, 24-month non-solicit, indefinite confidentiality.","New agreement dated Oct 30, 2024 supersedes prior July 2023 employment contract."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193769,"accession_number":"0001104659-24-110349","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-10-22T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"AdaptHealth appoints Diana Nole to Board of Directors effective Oct 16, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Diana Nole, age 59, appointed as Class I director; term expires at 2026 annual meeting.","Most recently EVP & GM of Healthcare at Nuance Communications (Microsoft); previously CEO of Wolters Kluwer Healthcare.","Board determined she is independent under Nasdaq and SEC rules.","Will receive standard non-employee director compensation, pro-rated for current year.","Company entered into indemnification agreement with Nole, form filed as Exhibit 10.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210098,"accession_number":"0001104659-24-104290","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-09-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"AdaptHealth corrects private warrant expiry to Nov 8, 2024 from previously reported Nov 20","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Notice to private placement warrant holders confirms expiration date is November 8, 2024 at 5:00 PM ET.","Company previously incorrectly reported expiration as November 20, 2024 in periodic filings.","Any warrants not exercised by the Expiration Date become void.","Terms of warrants unchanged; exercise still subject to Warrant Agreement conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210097,"accession_number":"0001104659-24-100033","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-09-16T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"AdaptHealth closes $950M senior secured credit facility, extends maturity to 2029, reduces cost of debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New facility: $650M Term Loan A (fully funded) + $300M Revolver, replacing $450M revolver and existing term loan due Jan 2026.","Maturity extended to September 13, 2029; interest rate pricing decreased from prior credit facility.","Proceeds used to fully repay existing Term Loan with no penalty; undrawn commitment fees reduced.","13 lenders including Regions Bank, BofA, Capital One, Citizens, Fifth Third, JPMorgan, Truist."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210096,"accession_number":"0001104659-24-092623","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-08-26T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"AdaptHealth appoints Scott Barnhart as COO; Shaw Rietkerk transitions to Chief Business Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Scott Barnhart appointed COO effective Sep 23, 2024; previously COO of Qurate Retail Group and President at Cardinal Health.","Barnhart receives $600K base salary, 100% target bonus, and $1M RSU inducement grant vesting over 3 years.","Shaw Rietkerk moves to Chief Business Officer until Mar 31, 2025; receives $750K transition payment and continued equity vesting.","Rietkerk waives 2024 target bonus and contractual severance in exchange for transition benefits.","Barnhart brings 30+ years ops experience; CEO says change supports organizational alignment and growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210095,"accession_number":"0001104659-24-090892","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-08-19T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"AdaptHealth COO Shaw Rietkerk to step down, named Chief Business Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Shaw Rietkerk informed by AdaptHealth on Aug 13, 2024 of planned transition to Chief Business Officer.","Rietkerk will cease serving as COO by end of September 2024; new role effective thereafter.","Company and Rietkerk are currently negotiating terms of the transition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210094,"accession_number":"0001628280-24-034954","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"AdaptHealth Q2 revenue $806M (+1.6% YoY); net income $19.4M; narrows guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $806.0M vs $793.3M YoY; net income $19.4M (+39%); adjusted EBITDA $165.3M (-3.3%).","Year-to-date operating cash flow $247.0M (+$20.4M YoY); free cash flow $77.9M (+$23.1M).","Signed definitive agreement to divest certain non-core assets; closing expected Q3 2024.","FY2024 guidance: net revenue $3.255-3.315B, adj. EBITDA $660-700M, free cash flow $160-180M.","CEO Suzanne Foster noted results in line with expectations; optimistic about unified team effort."],"consensus_eps_estimate":null,"consensus_eps_actual":0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":1598472000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210093,"accession_number":"0001104659-24-077607","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-07-03T23:59:59+00:00","items":["5.02","7.01","8.01","9.01"],"status":"ready","headline":"AdaptHealth President Josh Parnes to resign, Dale Wolf named Board Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Josh Parnes steps down as President effective Aug 31, 2024, and from Board Dec 31, 2024.","Dale Wolf appointed Chair of Board effective July 1, 2024, replacing outgoing Chair Richard Barasch.","CEO Suzanne Foster joined Board effective May 20, 2024.","Parnes receives contractual severance, prorated 2024 bonus, and COBRA; equity treated as termination without cause."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228333,"accession_number":"0001104659-24-073974","cik":1725255,"company_name":"AdaptHealth Corp.","ticker":"AHCO","form_type":"8-K","filed_at":"2024-06-21T23:59:59+00:00","items":["5.02","5.03","5.07","9.01"],"status":"ready","headline":"AdaptHealth shareholders approve de-staggered board, officer exculpation, and 8.35M share increase to equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved board declassification; directors elected after 2024 will serve one-year terms, phase-out complete by 2026.","Stockholders approved officer exculpation amendment to certificate of incorporation under new Delaware law.","8,350,000 new shares added to 2019 Stock Incentive Plan; plan termination date extended to 2034.","Directors Terence Connors, Ted Lundberg, Joshua Parnes, David Williams III elected to one-year terms.","KPMG LLP ratified as independent auditor for FY 2024; advisory say-on-pay passed with 94.4M votes for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1378228528.7442086,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}